News – Page 18 – Asian Fund for Cancer Research

Imaging tumor stiffness could help enhance treatment for breast and pancreatic cancer

October 14, 2019 Global Cancer News

Using a non-invasive imaging technique that measures the stiffness of tissues gives crucial new information about cancer architecture and could aid the delivery of treatment to the most challenging tumours, new research shows. Magnetic resonance elastography was able to visualise and measure…

USCACA & AFCR 2019 Scholar Awards

October 8, 2019 AFCR News

The United States Chinese Anti-Cancer Association and AFCR are pleased to invite nominations for the USCACA-AFCR 2019 Scholar Awards. The Awards will recognize two to three junior Chinese investigators on the basis of signiﬁcant contributions in Translational or Clinical Cancer Research. Candidacy is open to…

Quest for new cancer treatment crosses milestone

October 2, 2019 Global Cancer News

A cancer therapy invented at Rice University has crossed a milestone in clinical trials, a major development in a decades long quest to develop a treatment that destroys tumors without the debilitating side effects of chemotherapy, invasive surgery and radiation. According to the…

Tasmanian devil research could help tackle immunotherapy resistance

October 2, 2019 Global Cancer News

A cluster of interacting proteins that are active in both human cancers and Tasmanian devil facial tumours, may give clues to how cancers evade the immune system. This early work in cells could one day guide us towards new drug combinations that…

Scientists evaluate cancer risk of US drinking water

September 25, 2019 Global Cancer News

Researchers from the Environmental Working Group (EWG) in Washington, DC, used a new approach to analyze cumulative cancer risk due to carcinogens in tap water across the U.S. This study is the first to apply a "cumulative cancer risk framework" to the analysis of tap…

Breakthrough in understanding enzymes that make antibiotic for drug-resistant pathogen

September 25, 2019 Global Cancer News

Acinetobacter baumannii is a pathogen that causes hospital-acquired infections that are very difficult to treat, because they are resistant to most currently available antibiotics. As one of the World Health Organization's three critical priority pathogens, new antibiotics for Acinetobacter baumannii are urgently needed, and is…

Disparities in toxic heavy metal exposures correlated with increased risk of breast cancer among minority populations

September 24, 2019 Global Cancer News

Among women in Chicago, African Americans and Hispanics were exposed to higher levels of ambient toxic heavy metals compared with non-Hispanic whites, and this increased exposure correlated with increased incidence of breast cancer. Garth Rauscher, Ph.D., associate professor of epidemiology at the…

Discovery of how colorectal cancer drug works will help more patients

September 24, 2019 Global Cancer News

Some colorectal cancer patients with a certain gene mutation benefit from a chemotherapy drug called cetuximab, although the mechanism of how this drug worked was unknown. Scientists have combined computational biology with experimental investigations to discover, for the first time, the mechanism…

BRACE Program Launched by Asian Fund for Cancer Research

September 23, 2019 AFCR News

FOR IMMEDIATE RELEASE: September 23, 2019 CONTACTS: Asian Fund for Cancer Research Bradley Gillenwater, Senior Director for Global Programs & Communications E-mail: bgillenwater@afcr.org Hugill & Ip Solicitors Marco Raccuia, Operations & Marketing Specialist E-mail: marco.raccuia@hugillandip.com Inaugural BRACE Award Competition winner F. Joel Leong, flanked by…

4 gold molecules point to the future of cancer treatment

September 21, 2019 Global Cancer News

For the past few decades, platinum based cisplatin has been a compound of choice in the treatment of many cancers. It is especially effective at halting testicular cancer, with a success rate of more than 90%. However, the usefulness of cisplatin and other metal…